<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: Idiopathic <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo> can be a sign of <z:e sem="disease" ids="C0442893" disease_type="Disease or Syndrome" abbrv="">systemic disease</z:e> since certain complications are frequently associated: cerebral thrombotic events in <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e>, necrotic ulcerations of the lower limbs </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0003613'>Antiphospholipid antibodies</z:hpo> have been found in 0 to 85 p </plain></SENT>
<SENT sid="2" pm="."><plain>100 of patients with <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e> and anti-beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> 1 antibodies in 65 p </plain></SENT>
<SENT sid="3" pm="."><plain>100 of a series of 20 cases with <z:e sem="disease" ids="C0282492" disease_type="Disease or Syndrome" abbrv="">Sneddon's syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The aim of our study was to determine the prevalence of anti-beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> 1 antibodies in idiopathic <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>PATIENTS AND METHODS: Twelve patients in a series of 17 with idiopathic <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo> seen between 1981 and 1992 were studied progressively </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> underwent a clinical examination and simple laboratory tests with search for anticardiolipin antibodies, <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> type circulating <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> and anti-beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> 1 antibodies </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: Eight of our 12 patients (60 p </plain></SENT>
<SENT sid="8" pm="."><plain>100) were positive for anti-beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> 1 antibodies, 3 of whom also had episodes of <z:mp ids='MP_0005048'>thrombosis</z:mp> similar to those described in <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Only one of the 8 patients also had anticardiolipin antibodies and no <z:hpo ids='HP_0011010'>chronic</z:hpo> manifestation of <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>DISCUSSION: beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> 1 is a cofactor which increases anticardiolipin antibody <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> to <z:chebi fb="0" ids="28494">cardiolipin</z:chebi> in ELISA </plain></SENT>
<SENT sid="11" pm="."><plain>Anti-beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> 1 antibodies are associated with <z:mp ids='MP_0005048'>thrombosis</z:mp> and <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> with <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Our results would suggest that the prevalence of anti-beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> 1 antibodies is high in idiopathic livedo, but, due to the small number of patients, do not allow confirmation that anti-beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> 1 antibodies are associated with <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="13" pm="."><plain>Anti-beta 2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> 1 antibody assay would be justified in routine evaluation of patients with livedo and at follow-up examinations </plain></SENT>
</text></document>